biocon

Though, the net sales of Biotechnology Company, Biocon was up by 10% amounting to Rs. 441.68 crore, its net profit decreased by 9% amounting to Rs 70.05 crore. The fall has led the company’s s…

Biocon Net profit rose 200.91% to Rs 72.64 crore in Qtr ending March 2010 for the financial year 2009-2010 compared toRs 24.14 crore in qtr ending March 2009. Sales rose 47.71% to Rs 327.32 crore in Qtr ending March 2010 for the financial year 2009-2010 compared toRs 221.60 crore in qtr ending March 2009. [...]

Biocon Results – Announces Qtr Ending March 2010 results is a post from: First Blog for Indian Financial Market

Biocon net profits rise 3.24 times in forth quarter

Biotechnology major, Biocon Ltd on Thursday said that its consolidated net profit rose 3.24 times to Rs 80.62 crore in the forth quarter ended March 2010 compared to Rs 24.88 crore in the same period last year.

The consolidated net sales of the Bangalore based company rose to Rs 56.84 crore in the forth quarter of 2009-10 against Rs 466.26 crore in the same quarter of 2008-09. Biocon declared a dividend of Rs 3.50 per share.

Biocon Ltd. Takes Full Ownership of Biocon Biopharmaceuticals

It has been reported that biotechnology chief Biocon, has completely got hold of the mutual project Biocon Biopharmaceuticals from its Cuban partner CIMAB.

It is said that under the industry reformation strategy, Biocon will pick up CIMAB’s 49% stake and will make Biocon Biopharmaceuticals (BBPL) an entirely possessed ancillary of Biocon.

The financial details of the deal were not declared by the company.

But CMD, Kiran Mazumdar Shaw, told ET that the takeover was funded through internal accumulations.